The Effect of Anesthesia on Cerebral Oxygenation

Sponsor
Karadeniz Technical University (Other)
Overall Status
Completed
CT.gov ID
NCT04760262
Collaborator
(none)
30
1
34.7
0.9

Study Details

Study Description

Brief Summary

One-lung ventilation (OLV) may cause negative changes in the oxygenation of cerebral tissue which results in postoperative cognitive dysfunction. The aim of this prospective study was to compare the potential effects of TIVA and inhalation general anesthesia techniques on cerebral tissue oxygenation and postoperative cognitive functions in patients receiving one-lung ventilation in thoracic surgery

Detailed Description

One-lung ventilation (OLV) is a commonly used technique in thoracic surgeries. In thoracic surgeries performed with OLV, there may be changes in cerebral tissue oxygenation depending on both patient position and anesthetic technique. The effect of cerebral hypoxia on postoperative cognitive functions is controversially. Despite the ISPOCD1 study in which concluded that there were no relationship between the cerebral hypoxy and postoperative cognitive dysfunction (POCD) regional cerebral oxygen saturation decrements during surgery are listed among the POCD When OLV begins, alveolar hypoxia and arteriovenous shunt of deoxygenated blood occur in the dependant lung. And then, hypoxic pulmonary vasoconstriction (HPV) in non-ventilated lung segments occurs with increased mechanical stress. This event lead to significant physiological changes in cardiac output and pulmonary and systemic pressures In OLV, the propofol-based total intravenous anesthesia (TIVA) and inhalation general anesthesia techniques are frequently used. Recent studies have shown that unlike inhalational anesthetics, propofol does not suppress HPV, indeed increases it (Inhalational anesthetic agents reduce cardiac output more than oxygen consumption, causing a decrease in mixed venous partial pressure of oxygen, which stimulates hypoxic pulmonary vasoconstriction . Studies have shown significant reductions in cerebral oxygen saturation in thoracic surgery as a result of severe oxidative stress due to prolonged OLV and hypoxemia due to decreased functional residual capacity of the ventilated lung in the lateral decubitus position Cerebral oximetry is a method used to monitor the cerebral oxygen distribution-consumption balance and regional oxygen saturation (rSO2) in a limited area of the frontal cortex by noninvasively and continuously combining arterial and venous oxygen saturation signals of near-infrared spectroscopy (NIRS), which is a technique developed in the 1970s. Thanks to this method, perioperative physiological conditions, optimal tissue oxygenation and end-organ functions can be interpreted The aim of this prospective study was to compare the potential effects of TIVA and inhalation general anesthesia techniques on cerebral tissue oxygenation and postoperative cognitive functions in patients receiving one-lung ventilation in thoracic surgery

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Effect of Different Anesthesia Techniques on Cerebral Oxygenation in Thoracic Surgery
Actual Study Start Date :
Mar 1, 2017
Actual Primary Completion Date :
Jun 15, 2019
Actual Study Completion Date :
Jan 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Group Propofol

anesthesia was maintained with TIVA (intravenous 125-250 µg/kg/min propofol + 0.1-0.25 µg/kg/min remifentanil infusion)

Drug: Propofol
BIS values were arranged 40-60 until the end of operation, In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased
Other Names:
  • Remifentanil
  • Group Sevoflurane

    anesthesia was maintained with inhalation (sevoflurane concentration of 1-2% in 50-50% O2-air mixture).

    Drug: Sevoflurane
    Sevoflurane %2-3 for general anesthesia maintenance, BIS values were arranged 40-60 until the end of operation, In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased

    Outcome Measures

    Primary Outcome Measures

    1. Near Infrared Spectroscopy [Duration of surgery]

      Cerebral oxygen saturation as measured by Near Infrared Spectroscopy

    2. Mini mental state examination (MMSE) [3 to 24 hours postoperative period]

      Mini mental state examination (MMSE) to evaluate patients' cognitive functions

    Secondary Outcome Measures

    1. mean arterial pressure [Duration of surgery]

      The effect of anesthetics on mean arterial pressure

    2. heart rate [Duration of surgery]

      The effect of anesthetics on heart rate

    3. bispectral index [Duration of surgery]

      The effects of sevoflurane and desflurane on bispectral index

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients in American Society of Anesthesiology (ASA) classification I and II

    • Patients who would undergo thoracic surgery with one-lung ventilation (OLV)

    • thoracic surgeries with one-lung ventilation (OLV) that will take at least 45 minutes

    Exclusion Criteria:
    • Patients in ASA classification III and higher

    • Emergency surgery

    • Patients with known allergy to drugs used in the study

    • Patients in New York Heart Association classification III-IV

    • severe metabolic, renal, hepatic, central nervous system diseases, alcohol or drug addiction

    • multiple trauma, coagulapathy, cerebral disease, dementia, hearing impairment and imperception

    • severe obesity (a body mass index (BMI) of ≥ 35)

    • patients with a peripheral oxygen saturation below 90 during one lung ventilation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Karadeniz Technical University Trabzon Turkey 61080

    Sponsors and Collaborators

    • Karadeniz Technical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Ali AKDOĞAN, assistant professor, Karadeniz Technical University
    ClinicalTrials.gov Identifier:
    NCT04760262
    Other Study ID Numbers:
    • 2013/21
    First Posted:
    Feb 18, 2021
    Last Update Posted:
    Feb 18, 2021
    Last Verified:
    Feb 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Ali AKDOĞAN, assistant professor, Karadeniz Technical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 18, 2021